Skip to main content

Animations

MJFF Publications

5831 - 5840 of 9134 Results
Title
Year
  • Year
  • 2022
  • 2025
  • 2025
  • 2026
  • 2026
  • 2026
  • 2023
  • 2026
  • 2024
  • 2025
  • Summary Details
    OPEN
    Title: Photoreceptor Enhanced Light Therapy (PELT): A Framework for Implementing BiologicallyDirected Integrative Lighting
    Journal Name: LEUKOS
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1080/15502724.2022.2123816
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Magnetoelectric nanoparticle technology for mitigating motor deficits in Parkinsonian mice
    Journal Name: Brain Stimulation
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.brs.2025.08.008
    Citation Count: 4
  • Summary Details
    OPEN
    Title: A prospective controlled study of a wearable rhythmic vibrotactile device for tremor in Parkinson’s disease
    Journal Name: Clinical Neurophysiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.clinph.2025.02.255
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Aging and metabolism contribute separately to brain–body health
    Journal Name: PLOS Biology
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pbio.3003856
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Prion propagation is controlled by a hierarchical network involving the nuclear Tfap2c and hnRNP K factors and the cytosolic mTORC1 complex
    Journal Name: PLOS Pathogens
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.ppat.1014056
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Dissecting genotype-specific effects of disease-associated genetic variants
    Journal Name: iScience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.isci.2026.116143
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Targeting sleep and the circadian system as a novel treatment strategy for Parkinson’s disease
    Journal Name: Journal of Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00415-023-12073-7
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Vaccines mimicking conformational epitopes on α-synuclein fibrils provide immunity to Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awag010
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Survival and maturation of human induced pluripotent stem cell-derived dopaminergic progenitors in the parkinsonian rat brain is enhanced by transplantation in a neurotrophin-enriched hydrogel
    Journal Name: Journal of Neural Engineering
    Publisher: IOP Publishing
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1088/1741-2552/ad33b2
    Citation Count: 16
  • Summary Details
    OPEN
    Title: TMEM175, SCARB2 and CTSB associations with Parkinson’s disease risk across populations
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-01180-z
    Citation Count: 4
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.